A novel germline PAX5 single exon deletion in a pediatric patient with precursor B-cell leukemia von van Engelen, N., Roest, M., van Dijk, F., Sonneveld, E., Bladergroen, R., van Reijmersdal, S. V., van der Velden, V. H. J., Hoogeveen, P. G., Kors, W. A., Waanders, E., Jongmans, M. C. J., Kuiper, R. P.

Volltext

Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia von Marke, R, Havinga, J, Cloos, J, Demkes, M, Poelmans, G, Yuniati, L, van Ingen Schenau, D, Sonneveld, E, Waanders, E, Pieters, R, Kuiper, R P, Hoogerbrugge, P M, Kaspers, G J L, van Leeuwen, F N, Scheijen, B

Volltext

Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition von Diets, I J, Nagtegaal, I D, Loeffen, J, de Blaauw, I, Waanders, E, Hoogerbrugge, N, Jongmans, M C J

Volltext

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL von Kuiper, R P, Waanders, E, van der Velden, V H J, van Reijmersdal, S V, Venkatachalam, R, Scheijen, B, Sonneveld, E, van Dongen, J J M, Veerman, A J P, van Leeuwen, F N, Geurts van Kessel, A, Hoogerbrugge, P M

Volltext

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences von Waanders, E, Scheijen, B, Jongmans, M C J, Venselaar, H, van Reijmersdal, S V, van Dijk, A H A, Pastorczak, A, Weren, R D A, van der Schoot, C E, van de Vorst, M, Sonneveld, E, Hoogerbrugge, N, van der Velden, V H J, Gruhn, B, Hoogerbrugge, P M, van Dongen, J J M, Geurts van Kessel, A, van Leeuwen, F N, Kuiper, R P

Volltext

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia von Waanders, E, van der Velden, V H J, van der Schoot, C E, van Leeuwen, F N, van Reijmersdal, S V, de Haas, V, Veerman, A J, van Kessel, A Geurts, Hoogerbrugge, P M, Kuiper, R P, van Dongen, J J M

Volltext

Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma von van Engelen, N., van Dijk, F., Waanders, E., Buijs, A., Vermeulen, M. A., Loeffen, J. L. C., Kuiper, R. P., Jongmans, M. C. J.

Volltext

Independent development of lymphoid and histiocytic malignancies from a shared early precursor von Waanders, E, Hebeda, K M, Kamping, E J, Groenen, P J T A, Simons, A, Hoischen, A, Jongmans, M C J, Hoogerbrugge, P M, van Leeuwen, F N, Kuiper, R P, te Loo, D M W M

Volltext

1394 COPY NUMBER ASSAY IN POLYCYSTIC LIVER DISEASE BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION von Maurits, J.S.F, Cnossen, W.R, Waanders, E, te Morsche, R.H.M, Drenth, J.P.H

Volltext

TET2 mutations in childhood leukemia von Langemeijer, S M C, Jansen, J H, Hooijer, J, van Hoogen, P, Stevens-Linders, E, Massop, M, Waanders, E, van Reijmersdal, S V, Stevens-Kroef, M J P L, Zwaan, C M, van den Heuvel-Eibrink, M M, Sonneveld, E, Hoogerbrugge, P M, Geurts van Kessel, A, Kuiper, R P

Volltext

Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63 von Waanders, E, Venselaar, H, Te Morsche, RHM, De Koning, DB, Kamath, PS, Torres, VE, Somlo, S, Drenth, JPH

Volltext

Response to Palmirotta et al.: The frequency of the PRKCSH GAG trinucleotide repeat in PCLD patients von Waanders, E, Janssen, MJ, Drenth, JPH

Volltext

46 IN AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE (PCLD) CYSTS DEVELOP THROUGH A CELLULAR RECESSIVE MECHANISM INVOLVING LOSS OF HETEROZYGOSITY AND SOMATIC MUTATIONS von Janssen, M.J, Waanders, E, Dijkman, H.B.P.M, te Morsche, R.H.M, Woudenberg, J, Drenth, J.P.H

Volltext

890 CA19-9 IS A NOVEL BIOMARKER FOR POLYCYSTIC LIVER DISEASE von Waanders, E, Sweep, F.C.G.J, van Keimpema, L, Drenth, J.P.H

Volltext

On the monophyly of chromalveolates using a six-protein phylogeny of eukaryotes von Harper, James T, Waanders, Esme, Keeling, Patrick J

Volltext

Comment on: How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? von Waanders, E, van Keimpema, L, Drenth, J.P.H

Volltext

Highly sensitive MRD tests for ALL based on the IKZF1 Δ3–6 microdeletion von Venn, N C, van der Velden, V H J, de Bie, M, Waanders, E, Giles, J E, Law, T, Kuiper, R P, de Haas, V, Mullighan, C G, Haber, M, Marshall, G M, MD, Norris, van Dongen, J J M, Sutton, R

Volltext

Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma von van Engelen, N, van Dijk, F, Waanders, E, Buijs, A, Vermeulen, M. A, Loeffen, J. L.C, Kuiper, R. P, Jongmans, M. C.J

Volltext

Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition von Diets, I J, Nagtegaal, I D, Loeffen, J, de Blaauw, I, Waanders, E, Hoogerbrugge, N, Jongmans, M C J

Volltext

Value of molecular analysis of Wilson's disease in the absence of tissue copper deposits : a novel ATP7B mutation in an adult patient von KOK, K. F, HOEVENAARS, B, WAANDERS, E, DRENTH, J. P. H

Volltext